Quality Assesment of Antibiotic Prescription for Sepsis Treatment in Intensive Care Unit at Top Referral Hospital in West Java, Indonesia by Adani, Shadrina Dinan et al.
Althea Medical Journal. 2017;4(2)
286     AMJ June 2017
Quality Assesment of Antibiotic Prescription for Sepsis Treatment in 
Intensive Care Unit at Top Referral Hospital in West Java, Indonesia 
Shadrina Dinan Adani,1Ardi Zulfariansyah,2 Putri Teesa3 1Faculty of Medicine Universitas Padjadjaran, 2Department of Anesthesiology and Intensive Care Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung, 3Department of Anatomy, Biology Cell and Physiology Faculty of Medicine Universitas Padjadjaran
Abstract
Background: Sepsis is a common disease in intensive care unit (ICU) with high mortality rate. Administration of antibiotic has an important role to determine the outcome of sepsis patient. This study aimed to evaluate the quality of antibiotic prescription for sepsis treatment in intensive care unit (ICU). 
Methods: This descriptive study was conducted by retrieving data from 48 medical records of patients with sepsis, severe sepsis, and septic shock admitted to ICU  Dr. Hasan Sadikin General Hospital (RSHS) in 2013. The study was conducted from August to October 2014. Empiric therapy in the ICUat RSHS and Surviving Sepsis Campaign (SSC) guidelines in 2012 were used as a standard for antibiotic prescription. The quality of antibiotic prescription was assessed then categorized based on Gyssens criteria. The collected data were analyzed in the form of frequency and percentage and presented in tables.
Results: This study discovered that most of the patients had severe sepsis and septic shock. Based on Gyssens criteria, 35% antibiotic uses were included into category 0 (proper); 1.4% category I (improper timing); 10.5% category IIA (improper dosage); 9.1% category IIB (improper interval); 3.5% category IIC (improper route); 12.6% category IIIA (improper duration; too long); 1.4% category IIIB (improper duration; too short); 16.8% category IVA (improper; other antibiotics were more effective); 4.2% category IVD (improper; other antibiotics had narrower spectrum); and 5.6% category V (improper; no indication).
Conclusions: There are still improper uses of antibiotic for sepsis, severe sepsis, and septic shock patients in the ICU.
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IntroductionSepsis is a systemic response to infection that can result to severe sepsis (acute organ dysfunction caused by an infection that is already known in advance) and septic shock (severe sepsis plus hypotension that is not 
improved after fluid resuscitation).1 Sepsis is a common disease in Intensive Care Unit (ICU), in which 6–30% patients treated have sepsis.2 A study in Spain reported the mortality of sepsis patients admitted to hospital; patients with sepsis are 12.8%; patients with severe sepsis are 20.7%; while patients with septic shock are 45.7%.3 In addition, another study in Spain reported that sepsis is the second largest cause of death in ICU with mortality in 
the first 48 hours of admission is 14.8%.4
Surviving Sepsis Campaign (SSC) guidelines in 2012 discussed about the management of severe sepsis and septic shock with the aim to improve the outcome of treatment, so that the incidence and mortality of sepsis will decrease.1 However, based on studies regarding treatment of patient with sepsis, it turns out that there are still treatments or actions that are not according to SSC guidelines, thus, morbidity and mortality increase.5 One of the treatments that is still not appropriate according to SSC guidelines is antibiotic treatment. Because there is no study data regarding antibiotic uses in the ICU at Dr. Hasan Sadikin General Hospital (RSHS) Bandung, especially in patients with sepsis, severe sepsis, and septic shock, this study was conducted to assess the quality of   antibiotic 
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prescription in patients with sepsis, severe sepsis, and septic shock in the ICU at RSHS Bandung in 2013.
MethodsThe study was conducted from August to October 2014 using quantitative descriptive study method. The study was approved by the Health Research Ethics Committee 
RSHS Bandung. The data were collected retrospectively using secondary data recorded in the Medical Record Installation RSHS. Samples were then determined by total sampling technique including patients with sepsis, severe sepsis, and septic shock admitted to ICU in 2013. The data collected from medical records were patient demographics (name, age, and gender), indication (diagnosis and results of culture examination with its resistance to antibiotic), name of administered 
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Figure 1 Flow Chart for Evaluation of Antibiotic Prescription     Source: Gyssens et al.6
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antibiotic, dose, timing, route, frequency, and its duration of administration; also mortality.The antibiotic prescriptions in the ICU at RSHS were adjusted to the standard of empiric therapy (guidelines of antibiotic use that have 
been agreed and should be applied in the ICU at RSHS) and also prescription uses were then 
assessed using flow chart of Gyssens criteria 2001 (Figure 1) that was divided into 0–VI category, namely proper use of antibiotic 
Table 1 Distribution of the Number of Sepsis, Severe Sepsis, and Septic Shock Cases based 
  on the Characteristics of the Patients
Variable Sepsis n(%)
Severe Sepsis 
n(%)
Septic Shock 
n(%)
Total 
n(%)Age    17–50 years old 4 (26.7) 4 (30.8) 9 (45) 17 (35.4)    51–87years old 11 (73.3) 9 (69.2) 11 (55) 31 (64.6)Gender    Female 7 (46.7) 8 (40) 6 (46.2) 21 (43.8)    Male 8 (53.3) 12 (60) 7 (53.8) 27 (56.3)Total 15 20 13 48
Table 2 Distribution of Quality of Antibiotic Uses based on the Severity of Sepsis
Variable Sepsis n(%)
Severe Sepsis 
n(%)
Septic Shock 
n(%)
Total 
n (%)Indication    Proper indication 33 (97) 43 (87.8) 34 (97.1) 110 (93.2)    Improper indication 1 (3) 6 (12.2) 1 (2.9) 8 (6.8)Antibiotic    Proper antibiotic 25 (75.8) 29 (67,4) 26 (76.5) 80 (72.7)    Improper antibiotic 8 (24.2) 14 (32.6) 8 (23.5) 30 (27.3)Timing    Proper timing 33 (100) 41 (95.3) 34 (100) 108 (98.2)    Improper timing 0 (0) 2 (4.7) 0 (0) 2 (1.8)Dose    Proper dose 29 (87.9) 40 (93) 26 (76.5) 95 (86.4)    Improper dose 4 (12.1) 3 (7) 8 (23.5) 15 (13.6)Route    Proper route 30 (90.9) 41 (95.3) 34 (100) 105 (95.5)    Improper route 3 (9.1) 2 (4.7) 0 (0) 5 (4.5)Interval    Proper interval 28 (84.8) 39 (90.7) 30 (88.2) 97 (88.2)    Improper interval 5 (15.2) 4 (9.3) 4 (11.8) 13 (11.8)Duration    Proper duration 22 (66.7) 36 (83.7) 32 (94.1) 90 (81.8)    Too long 10 (30.3) 6 (14) 2 (5.9) 18 (16.4)    Too short 1 (3) 1 (2.3) 0 (0) 2 (1.8)
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(0); improper timing of administration (I); improper dose of administration (IIA); improper interval of administration (IIB); improper route of administration (IIC); improper duration of administration due to long administration (IIIA) and very short administration (IIIB); improper type of antibiotic due to other more effective antibiotics (IVA), other safer antibiotics with low toxicity (IVB), other cheaper antibiotics (IVC), other narrower spectrum antibiotics (IVD); improper indication (V); and the data in medical record were incomplete as well that could not be evaluated (VI).6The data were analyzed descriptively with quantitative approach in the form of frequencies and percentages presented in tables.
ResultsThere were 48 sepsis cases admitted to ICU in 2013, including 31.2% sepsis, 41.7% severe sepsis, and 27.1% septic shock. Most of the cases were found in males and in patients above 50 years old (Table 1).There were 118 antibotic uses including 86 
empiric therapies and 32 definitive therapies in 48 patients with sepsis, severe sepsis, and septic shock in the ICU. Improper uses of antibiotic were mostly due to incompatibility in the type of antibiotic and administration duration (Table 2).The quality assessment of antibiotic 
prescription based on flow chart of Gyssens criteria were conducted in all administered antibiotics and obtained 143 units of analysis in 118 uses of antibiotics. The results of quality of antibiotic prescription in treatment of sepsis, severe sepsis, and septic shock in the ICU (category 0 Gyssens criteria) were found to be proper in 35% of the antibiotic prescription (Table 3).The incidence of mortality based on the severity of sepsis was found mostly prescription, mortality occurred more frequently in patients who received antibiotics improperly (56.3%) (Table 4).
DiscussionBased on the study, incidence of sepsis, severe sepsis, and septic shock occurred more frequently in elderly patients (>50 years old) 
Table 3 Distribution of Quality of Antibiotic Uses based on Gyssens Criteria
Gyssens Criteria Amount (n) Percentage (%)Category 0 50 35 %Category I 2 1.4 %Category IIA 15 10.5 %Category IIB 13 9.1 %Category IIC 5 3.5%Category IIIA 18 12.6 %Category IIIB 2 1.4 %Category IVA 24 16.8 %Category IVD 6 4.2 %Category V 8 5.6 %Total 143 100 %
Table 4 Incidence of Mortality based on the Quality of Antibiotic Prescription and Severity 
of Sepsis
Mortality Sepsis n(%)
Severe Sepsis 
n(%)
Septic Shock 
n(%)
Total 
n(%)Category 0 3 (23) 4 (26.7) 5 (45.5) 12 (25)Category I-V 10 (77) 11 (73.3) 6 (54.5) 27 (56.3)Total 13 (33.3) 15 (38.5) 11 (28.2) 39 (81.3)
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and male patients. This is in accordance with a study conducted by Martin et al.7 which found the incidence of sepsis increases by 20.4% in patients older than 60 years old and the possibility for male patients suffering from sepsis is higher than female patients. Old age is a risk factor for infection. The elderlies are vulnerable because their immune systems 
may not be able to fight infection. In general, elderly patients with chronic diseases may spend time in hospital much longer so that they become susceptible to the cause of infection. In addition, the use of medical devices such as catheters to the elderly patients also increases the risk of infection.8 Besides age, gender also affects the immune system. A study conducted by Aulock et al.9 in 2006 found differences in the immune defense capabilities between men and women. When there is an infection, blood in males produce more cytokines such as tumor 
necrosis factor-alpha (TNF-α), interleukin-1β 
(IL-1β), IL-6, and IL-8 in response to the high concentration of lipopolysaccharide (LPS) endotoxins from gram negative bacteria or lipoteichoic exotoxins from gram positive 
bacteria. If the inflammatory response is widespread and unregulated, it will cause men to be more susceptible to infection and sepsis.9The quality of antibiotic prescription in patients with sepsis in the ICU was assessed 
using Gyssens criteria flow, including the indication of antibiotic, the type of administered antibiotic, the dose and route of administration, also the interval and duration of administration.6 This study discovered improper antibiotic prscription in all variables of those Gyssens criteria. A total of 110 administered antibiotics were given with a proper indication, while 8 other administered antibiotics not proper with the source of infection. Improper use of antibiotics most commonly found was choosing the type of antibiotics. Based on Gyssens criteria, selection of the type of antibiotic was considered proper if there is no other antibiotic which is more effective, with lower toxicity, or with narrower spectrum.6 Based on SSC guidelines, the choice of empirical antibiotic therapy should depend on sensitivity of pathogens that cause infections in hospital and patients clinical conditions such as drug intolerances, underlying disease, and clinical syndrome. Administered empirical antibiotic must be able to cover all possible pathogens that cause infections. After 3–5 days of empirical antibiotic administration, the management of sepsis patient continued with 
definitive treatment as soon as the susceptibility 
profile is known.1 This study discovered some selection of the type of empirical antibiotic combination that was less effective because it was not in accordance with the list of bacteria and its sensitivity to antibiotics at Dr. Hasan Sadikin General Hospital Bandung in 2013. Besides that, in some cases, even combination therapies were not given. This contrasts with the SSC guidelines which recommend the administration of combination therapy for patient with respiratory failure, septic shock, and infections due to multidrug-resistant (MDR) microbes.1 After the laboratory results of bacterial culture are obtained, if the sensitivity results are different with previous empiric therapy that was already given, 
empiric therapy is replaced with definitive therapy according to laboratory result. However, in some patients, there were still also 
found some resistant definitive antibiotic uses, which were not in accordance with culture result and its resistance from laboratory, such 
as ceftriaxone, ceftazidime, ciprofloxacin, and meropenem.The second highest improper use of antibiotic was found in the duration of antibiotic treatment (Table 2). Based on SSC guidelines, empirical antibiotic combinations should not be used more than 3–5 days. Initiation of empiric antibiotic treatment should be evaluated periodically after 48–72 hours based on the causal microbes and also the clinical condition of patient in order to give the narrower spectrum of antibiotic. If the test results of the sensitivity of bacteria 
have been known, definitive therapy should be given immediately.1 This study found a total of 18 empiric antibiotic treatments that are not in accordance with SSC guidelines because the treatment was given more than 5 days even more than 2 weeks. This is due to the culture results and resistances of bacteria that cause the infection was not obtained on 
time from laboratory, so the definitive therapy could not be administered. In this study, there were still many culture results and bacterial resistances obtained from laboratory for more than 5 days. In some cases, the culture and resistance examination were not even done. Excessive antibiotic treatment was not only detrimental to the patient in terms of cost, but also could cause bacteria to become resistant and increase in complication. Administered antibiotic for long time can cause side effects such as allergic reactions, antibiotic-associated colitis, and even death due to MDR.10 Bacterial resistance to antibiotics occurs through the changes of bacterial genetic structure such as 
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gene mutation. Genetic materials are capable of making the bacteria resistant through three main mechanisms, such as producing enzymes that inactivate or destroy antibiotics, changing the antibiotic target binding to the bacteria, and preventing access to the target itself.11Improper use of antibiotic was also found in the dose of administration. In general, the maximum dose of antibiotic given to sepsis patients in this study was already proper; however, in some patients with kidney disorders such as acute kidney injury (AKI) in advanced stage, chronic kidney disease (CKD), and end stage renal disease (ESRD), there was still found antibiotic treatment with high dosage. Kidney failure can be triggered by nephrotoxic drugs such as antibiotics vancomycin, aminoglycosides, and beta-lactam group. Most of the classes of those antibiotics are excreted through the kidneys so that in patients with renal impairment, the dose given shoud be lower than the standard usually applied.12Moreover, this study discovered that only 35% of antibiotic prescription for sepsis patients in the ICU at RSHS Bandung that was proper in accordance with the indication, type of antibiotic, timing, dose, route, interval, and duration (category 0 Gyssens criteria). Mortality rate was still considerably high (81.3%). The high incidence of mortality in sepsis patients can be caused by various factors, one of which is initiation of improper antibiotic treatment. Initial empiric antibiotic treatment that is adequate and continued 
with antibiotic treatment which is specific based on culture and its resistance result for sepsis patient treated in ICU is instrumental in determining outcome.13 Improper empiric 
and definitive antibiotic therapy effect on the outcome in this study, shown by incidence of mortality was more common in sepsis patient who received improper antibiotic treatment (56.3%), while in sepsis patient who received proper antibiotic treatment, incidence of mortality were only 25% (Table 4). This result is suitable with previous study in the United States. The study reported the percentage of survival rates of septic shock patients who received proper antibiotic treatment are 52%, while survival rates in patients who received improper antibiotic treatment are only 10.3%.14Limitations of this study were incomplete data in medical records so that the quality of antibiotic prescription could not be evaluated maximally. Given the importance of proper antibiotic use in order to achieve better 
outcomes for sepsis patient in ICU, further study needs to be conducted qualitatively to 
determine the factors that can influence the quality of improper antibiotic use in patients with sepsis, severe sepsis, and septic shock in ICU.Based on the result of this study, it can be concluded that there are still a lot of improper uses of antibiotics prescription in patients with sepsis, severe sepsis, and septic shock in the ICU at RSHS Bandung.
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